Gilead Sciences, Inc. (GILD)
143.72
-1.09
(-0.75%)
USD |
NASDAQ |
Sep 11, 16:00
143.80
+0.08
(+0.06%)
After-Hours: 20:00
Gilead Sciences Price : 143.72 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 145.24 | 145.99 | 143.50 | 143.72 | 4.202M |
| Sep 10, 2026 | 145.07 | 145.91 | 143.67 | 144.81 | 6.020M |
| Sep 09, 2026 | 145.46 | 147.68 | 145.00 | 145.65 | 4.583M |
| Sep 08, 2026 | 146.98 | 148.65 | 145.45 | 146.64 | 6.081M |
| Sep 04, 2026 | 149.23 | 151.18 | 149.23 | 151.00 | 6.182M |
| Sep 03, 2026 | 150.67 | 151.48 | 148.41 | 151.22 | 4.498M |
| Sep 02, 2026 | 150.00 | 152.55 | 148.83 | 149.61 | 4.923M |
| Sep 01, 2026 | 148.52 | 149.96 | 146.92 | 149.92 | 4.871M |
| Aug 31, 2026 | 144.23 | 147.22 | 143.18 | 146.34 | 6.595M |
| Aug 28, 2026 | 149.47 | 149.47 | 144.88 | 145.68 | 3.947M |
| Aug 27, 2026 | 147.30 | 149.10 | 146.01 | 148.86 | 5.015M |
| Aug 26, 2026 | 148.00 | 149.62 | 147.00 | 148.09 | 5.260M |
| Aug 25, 2026 | 146.60 | 148.94 | 145.58 | 148.77 | 4.631M |
| Aug 24, 2026 | 145.93 | 146.84 | 144.59 | 146.74 | 6.184M |
| Aug 21, 2026 | 144.52 | 147.90 | 143.50 | 146.12 | 5.385M |
| Aug 20, 2026 | 146.69 | 146.82 | 143.19 | 143.44 | 7.168M |
| Aug 19, 2026 | 145.10 | 148.97 | 144.30 | 147.60 | 6.739M |
| Aug 18, 2026 | 140.00 | 143.89 | 139.54 | 143.44 | 5.759M |
| Aug 17, 2026 | 138.36 | 139.49 | 136.63 | 138.92 | 3.940M |
| Aug 14, 2026 | 136.81 | 138.43 | 135.91 | 138.36 | 3.408M |
| Aug 13, 2026 | 136.94 | 138.30 | 136.03 | 138.14 | 4.897M |
| Aug 12, 2026 | 133.99 | 137.12 | 133.30 | 135.87 | 5.684M |
| Aug 11, 2026 | 132.68 | 136.85 | 132.01 | 135.77 | 5.494M |
| Aug 10, 2026 | 131.61 | 134.32 | 131.61 | 133.06 | 6.834M |
| Aug 07, 2026 | 132.10 | 134.09 | 130.59 | 133.21 | 8.202M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Vertex Pharmaceuticals, Inc. | 515.44 |
| AbbVie, Inc. | 257.12 |
| Regeneron Pharmaceuticals, Inc. | 781.49 |
| Amgen, Inc. | 377.35 |
| Biogen, Inc. | 217.15 |
Price Related Metrics
| PS Ratio | 5.886 |
| Price to Book Value | 15.08 |
| Price to Free Cash Flow | 13.89 |
| Earnings Yield | -1.85% |
| Market Cap | 178.36B |
| Operating PE Ratio | 15.07 |
| Normalized PE Ratio | 30.25 |